Postbiotic Therapeutics involves the clinical application of non-viable microbial cells, their cellular components, or their specific metabolites that confer a health benefit to the host. These therapeutic agents, which are the functional end-products of microbial fermentation, are administered to modulate the host’s physiological processes, particularly those related to immunity and metabolic health. This approach offers a targeted method to leverage the benefits of the microbiome without introducing live organisms.
Origin
The term is a modern refinement in the field of microbiome science, following the development of probiotics (live organisms) and prebiotics (substrate for organisms). “Postbiotic” signifies the biologically active substances produced after the microbial metabolic process. This shift in focus is driven by the desire for stability, precision, and safety in microbial-derived interventions.
Mechanism
Postbiotics function by directly interacting with host cells, including immune cells and colonocytes, often through pattern recognition receptors or specific signaling pathways. For instance, short-chain fatty acids, a class of postbiotics, can regulate gene expression and fortify the intestinal barrier. Administering these compounds directly provides a means to bypass potential colonization issues and rapidly deliver functional molecules that support metabolic and hormonal balance.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.